New tech serving cancer patients examine several symptoms
The early-stage colorectal cancer patients took part in the analysis of the eRAPID system. It is the first such analysis...
Latest Post
Pfizer research says that the COVID-19 vaccine works against new UK virus strain
The Pfizer study found that the vaccine appeared to work against 15 additional possible virus mutations, but E484K wasn't among...
10 infants die in Bhandara district hospital fire
Dr Khandate stated some babies were remitted at the hospital while others were brought from outside. The recovered babies were...
Bird flu confirmed in dead migratory birds in Himachal Pradesh’s Kangra, after cases reported in Rajasthan, MP and Kerala
Migratory birds found dead at Pong Dam Lake in Himachal Pradesh's Kangra district have tested positive for bird flu, according...
New Delhi AIIMS restarts elective surgeries after 10 months
After nearly 10 months, AIIMS has resumed nonemergency surgeries. It has also allowed pre-booking of appointments for OPD consultation directly...
‘Bharat Biotech vaccine licensed in clinical trial mode, the permission of participants has to be considered’: ICMR
"Permission for restricted use in clinical trial mode has been allowed, which means the consent of participants has to be...
Masks may never even go, says ICMR chief Balram Bhargava
THD NewsDesk, New Delhi: Moments following two vaccines were passed under contained use, and emergency use authorization by Directorate General of...
Incoming UK passengers to be tested for Covid on arrival till Jan 30
THD NewsDesk, New Delhi: In an SOP (standard operating procedure) issued on Saturday, the health ministry has stated that all...
Centre to set up drug parks to make chemicals: Union Minister D.V. Sadananda Gowda
Central Government has decided to set up 3 bulk drug parks to make chemical compounds or active pharmaceutical ingredients (APIs)...
CEPI assists in the advancement, development and manufacture of COVID-19 vaccine
Bio E initiated a Phase 1/2 clinical trial to evaluate the vaccine candidate's safety and immunogenicity in India in November...
